Tuesday, June 21, 2022 7:16:50 PM
Why do investors fear dilution when it's done at the right time and intended to build the company. I don't believe that the company would seriously dilute at todays prices. Once the trial is fully documented by the Journal and the company has ended the quiet period and brought the status of their activities over nearly the last two years up to date I believe our share price will be substantially higher. While I believe we'll authorize substantially more shares, not all that many will be needed to generate hundreds of millions of dollars.
Substantial dilution would be a possibility with an equity partnership, but it will add substantial value, and the stock should come up to roughly the price the BP partner agrees to pay. I believe that LP indicated that a buyout would be for no less than $20 billion, I would think she'd want essentially the same valuation on an equity partnership. I.E. if a BP partner were taking a 30% position in the stock they'd pay at lease $6 billion. It would make sense to me if half the shares were tendered by shareholders, and half were newly issued, so the company increased the outstanding share by 15%, and they'd have $3 billion to work with. I believe that nearly all shareholders would be happy with such a partnership and the share price it would bring.
I don't know it would go this way, but I believe it's the sort of arrangement that both the company and shareholders would be very happy with.
Gary
Substantial dilution would be a possibility with an equity partnership, but it will add substantial value, and the stock should come up to roughly the price the BP partner agrees to pay. I believe that LP indicated that a buyout would be for no less than $20 billion, I would think she'd want essentially the same valuation on an equity partnership. I.E. if a BP partner were taking a 30% position in the stock they'd pay at lease $6 billion. It would make sense to me if half the shares were tendered by shareholders, and half were newly issued, so the company increased the outstanding share by 15%, and they'd have $3 billion to work with. I believe that nearly all shareholders would be happy with such a partnership and the share price it would bring.
I don't know it would go this way, but I believe it's the sort of arrangement that both the company and shareholders would be very happy with.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
